Josh Cohen
Fondateur chez AMYLYX PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/05/2024
Profil
Joshua B.
Cohen is the founder of Amylyx Pharmaceuticals, Inc., where he holds the title of Co-Chief Executive Officer & Executive Director since 2014.
He is also the founder of Brown Biotechnology Investment Group.
Mr. Cohen's current job is as a Director at Practice XYZ LLC.
Mr. Cohen's education includes an undergraduate degree from Brown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2024 | 3 202 852 ( 4,71% ) | 6 M $ | 31/05/2024 |
Postes actifs de Josh Cohen
| Sociétés | Poste | Début |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Fondateur | 01/01/2013 |
Practice XYZ LLC
 Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Josh Cohen
| Sociétés | Poste | Fin |
|---|---|---|
| Brown Biotechnology Investment Group | Fondateur | - |
Formation de Josh Cohen
| Brown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Technology Services |
| Brown Biotechnology Investment Group |
